NICE guidance on the use of carmustine wafers in high grade gliomas: a national study on variation in practice

Stephen J Price; Ian R Whittle; Keyoumars Ashkan; Paul Grundy; Garth Cruickshank; UK-HGG Study Group

doi:10.3109/02688697.2012.673651

NICE guidance on the use of carmustine wafers in high grade gliomas: a national study on variation in practice

Stephen J Price, Ian R Whittle, Keyoumars Ashkan, Paul Grundy, Garth Cruickshank, UK-HGG Study Group

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Abstract

Multidisciplinary team (MDT) working in oncology aims to improve outcomes for patients with cancer. One role is to ensure the implementation of best practice and National Institute for Health and Clinical Excellence (NICE) guidance. In this study, we have assessed the role of MDT in implementing the TA121 appraisal of the use of carmustine wafers in high grade gliomas.

Original language	English
Pages (from-to)	331-5
Number of pages	5
Journal	British Journal of Neurosurgery
Volume	26
Issue number	3
DOIs	https://doi.org/10.3109/02688697.2012.673651
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/02688697.2012.673651

Cite this

@article{df0f39f5d9b6419fa2b76abfffeaeda1,

title = "NICE guidance on the use of carmustine wafers in high grade gliomas: a national study on variation in practice",

abstract = "Multidisciplinary team (MDT) working in oncology aims to improve outcomes for patients with cancer. One role is to ensure the implementation of best practice and National Institute for Health and Clinical Excellence (NICE) guidance. In this study, we have assessed the role of MDT in implementing the TA121 appraisal of the use of carmustine wafers in high grade gliomas.",

author = "Price, {Stephen J} and Whittle, {Ian R} and Keyoumars Ashkan and Paul Grundy and Garth Cruickshank and {UK-HGG Study Group}",

year = "2012",

doi = "10.3109/02688697.2012.673651",

language = "English",

volume = "26",

pages = "331--5",

journal = "British Journal of Neurosurgery",

publisher = "Taylor & Francis",

number = "3",

}

TY - JOUR

T1 - NICE guidance on the use of carmustine wafers in high grade gliomas

T2 - a national study on variation in practice

AU - Price, Stephen J

AU - Whittle, Ian R

AU - Ashkan, Keyoumars

AU - Grundy, Paul

AU - Cruickshank, Garth

AU - UK-HGG Study Group

PY - 2012

Y1 - 2012

N2 - Multidisciplinary team (MDT) working in oncology aims to improve outcomes for patients with cancer. One role is to ensure the implementation of best practice and National Institute for Health and Clinical Excellence (NICE) guidance. In this study, we have assessed the role of MDT in implementing the TA121 appraisal of the use of carmustine wafers in high grade gliomas.

AB - Multidisciplinary team (MDT) working in oncology aims to improve outcomes for patients with cancer. One role is to ensure the implementation of best practice and National Institute for Health and Clinical Excellence (NICE) guidance. In this study, we have assessed the role of MDT in implementing the TA121 appraisal of the use of carmustine wafers in high grade gliomas.

U2 - 10.3109/02688697.2012.673651

DO - 10.3109/02688697.2012.673651

M3 - Article

C2 - 22482926

VL - 26

SP - 331

EP - 335

JO - British Journal of Neurosurgery

JF - British Journal of Neurosurgery

IS - 3

ER -

NICE guidance on the use of carmustine wafers in high grade gliomas: a national study on variation in practice

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this